Publication | Closed Access

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

Medicinal ChemistryCisplatin-induced EmesisMedicineSelective Neurokinin-1 AntagonistNeuropharmacologyPharmacotherapyAnti-cancer AgentPharmacologyRadiation OncologyDrug DiscoveryNeuropeptides